What is driving today's activity in ALDEI.PA stock?

Today's activity is driven by unusually high volume of **13,014,939** shares and short-term trading interest in the microcap biotech. No confirmed market-moving news was posted at time of writing; volume likely reflects speculative repositioning and liquidity events.

What is Meyka AI's view and grade for ALDEI.PA stock?

Meyka AI rates ALDEI.PA with a score out of 100: **64.99 | Grade: B | Suggestion: HOLD**. The grade factors in sector and benchmark comparison, financials, growth and analyst consensus. This is informational, not investment advice.

How does the forecast compare to the current ALDEI.PA stock price?

Meyka AI's forecast model projects **€0.05**, versus the current price of **EUR 0.0265**, implying about **88.68%** upside under model scenarios. Forecasts are projections and not guarantees.

What are the main risks to owning ALDEI.PA stock?

Main risks include ongoing negative earnings, tight cash flow, potential dilution, and large intraday swings inherent to microcaps. Clinical trial setbacks or partner delays would hurt valuation.

EU Stocks

13.01M shares intraday: ALDEI.PA Deinove SA (EURONEXT) shows high activity

ByDanny Kontos February 6, 2026February 6, 2026

Today intraday ALDEI.PA stock is among the most active names on EURONEXT, exchanging 13,014,939 shares as traders respond to microcap volatility. The share price sits at €0.03 with a day range between €0.02 and €0.03. Volume is more than twice the average, at a relative volume of 2.17, underlining short-term liquidity and speculative flows for Deinove SA in Europe. We break down what the activity means for investors, the company’s fundamentals and a model-based short-term outlook.